157 related articles for article (PubMed ID: 21507403)
1. Endometrial ablation with the NovaSure system in Iran.
Asgari Z; Moini A; Samiee H; Tehranian A; Mozafar-Jalali S; Sabet S
Int J Gynaecol Obstet; 2011 Jul; 114(1):73-5. PubMed ID: 21507403
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Abbott J; Hawe J; Hunter D; Garry R
Fertil Steril; 2003 Jul; 80(1):203-8. PubMed ID: 12849825
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic appearance of endometrial cavity after microwave endometrial ablation.
Luo X; Lim CE; Li L; Wong WS
J Minim Invasive Gynecol; 2010; 17(1):30-6. PubMed ID: 20129329
[TBL] [Abstract][Full Text] [Related]
4. Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population.
Fakih M; Cherfan V; Abdallah E
Int J Gynaecol Obstet; 2011 May; 113(2):120-3. PubMed ID: 21420088
[TBL] [Abstract][Full Text] [Related]
5. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia.
Cooper J; Gimpelson R; Laberge P; Galen D; Garza-Leal JG; Scott J; Leyland N; Martyn P; Liu J
J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):418-28. PubMed ID: 12386350
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Long-Term NovaSure Endometrial Ablation Failure.
Lybol C; van der Coelen S; Hamelink A; Bartelink LR; Nieboer TE
J Minim Invasive Gynecol; 2018; 25(7):1255-1259. PubMed ID: 29550389
[TBL] [Abstract][Full Text] [Related]
7. NovaSure impedance controlled system for endometrial ablation: the experience of the first UK reference centre.
Elmardi A; Furara S; Khan F; Hamza M
J Obstet Gynaecol; 2009 Jul; 29(5):419-22. PubMed ID: 19603322
[TBL] [Abstract][Full Text] [Related]
8. Endometrial ablation with paracervical block.
Penninx JP; Mol BW; Bongers MY
J Reprod Med; 2009 Oct; 54(10):617-20. PubMed ID: 20677480
[TBL] [Abstract][Full Text] [Related]
9. [Endometrial ablation: comparative study between hysteroscopic resection and Novasure system].
Fresno-Alba S; DeLlera-Duarte A; Vidal-Roncero H; Usandizaga R; DeSantiago-Garcia J; Zapardiel I
Ginecol Obstet Mex; 2013 Apr; 81(4):175-9. PubMed ID: 23720928
[TBL] [Abstract][Full Text] [Related]
10. Improved premenstrual syndrome symptoms after NovaSure endometrial ablation.
Lukes AS; McBride RJ; Herring AH; Fried M; Sherwani A; Dell D
J Minim Invasive Gynecol; 2011; 18(5):607-11. PubMed ID: 21872168
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome after hydrothermal ablation treatment of menorrhagia in patients with and without submucous myomas.
Hachmann-Nielsen E; Rudnicki M
J Minim Invasive Gynecol; 2012; 19(2):212-6. PubMed ID: 22296749
[TBL] [Abstract][Full Text] [Related]
12. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
Kleijn JH; Engels R; Bourdrez P; Mol BW; Bongers MY
BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
[TBL] [Abstract][Full Text] [Related]
13. Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation.
Mengerink BB; van der Wurff AA; ter Haar JF; van Rooij IA; Pijnenborg JM
J Minim Invasive Gynecol; 2015 Feb; 22(2):239-44. PubMed ID: 25460320
[TBL] [Abstract][Full Text] [Related]
14. Women's satisfaction and symptoms following NovaSure endometrial ablation: a postal questionnaire survey in Lothian, Scotland.
Unger HW; Megaly E; Dick A; Horne AW; Milne S; West C
J Obstet Gynaecol; 2014 May; 34(4):350-1. PubMed ID: 24484297
[TBL] [Abstract][Full Text] [Related]
15. Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea.
Preutthipan S; Herabutya Y
J Obstet Gynaecol Res; 2010 Oct; 36(5):1031-6. PubMed ID: 20846253
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results.
Laberge P; Garza-Leal J; Fortin C; Grainger D; Johns DA; Adkins RT; Presthus J; Basinski C; Swarup M; Gimpelson R; Leyland N; Thiel J; Harris M; Burnett PE; Ray GF
J Minim Invasive Gynecol; 2017 Jan; 24(1):124-132. PubMed ID: 27687851
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of goserelin versus suction curettage prior to Thermachoice II balloon endometrial ablation: one-year results.
Vilos GA; Vilos AG; Abu-Rafea B
J Obstet Gynaecol Can; 2010 Oct; 32(10):973-9. PubMed ID: 21176307
[TBL] [Abstract][Full Text] [Related]
18. NovaSure endometrial ablation under local anaesthesia in an outpatient setting: An observational study.
Kalkat RK; Cartmill RS
J Obstet Gynaecol; 2011; 31(2):152-5. PubMed ID: 21281033
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis.
Liu Q; Li XL; Liu JJ; Song XH; Jiang XY; Li W; Zhang H; Pan CQ
J Obstet Gynaecol Res; 2016 Dec; 42(12):1753-1760. PubMed ID: 27647778
[TBL] [Abstract][Full Text] [Related]
20. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
